BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26862175)

  • 1. T cell-intrinsic S1PR1 regulates endogenous effector T-cell egress dynamics from lymph nodes during infection.
    Benechet AP; Menon M; Xu D; Samji T; Maher L; Murooka TT; Mempel TR; Sheridan BS; Lemoine FM; Khanna KM
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2182-7. PubMed ID: 26862175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells.
    Grigorova IL; Schwab SR; Phan TG; Pham TH; Okada T; Cyster JG
    Nat Immunol; 2009 Jan; 10(1):58-65. PubMed ID: 19060900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node cortical sinus organization and relationship to lymphocyte egress dynamics and antigen exposure.
    Grigorova IL; Panteleev M; Cyster JG
    Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20447-52. PubMed ID: 21059923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4
    Smith CJ; Allard DE; Wang Y; Howard JF; Montgomery SA; Su MA
    J Immunol; 2018 Mar; 200(5):1580-1592. PubMed ID: 29367208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S1PR1 inhibition induces proapoptotic signaling in T cells and limits humoral responses within lymph nodes.
    Dixit D; Hallisey VM; Zhu EY; Okuniewska M; Cadwell K; Chipuk JE; Axelrad JE; Schwab SR
    J Clin Invest; 2024 Jan; 134(4):. PubMed ID: 38194271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamin 2-dependent endocytosis is required for sustained S1PR1 signaling.
    Willinger T; Ferguson SM; Pereira JP; De Camilli P; Flavell RA
    J Exp Med; 2014 Apr; 211(4):685-700. PubMed ID: 24638168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress.
    Pham TH; Okada T; Matloubian M; Lo CG; Cyster JG
    Immunity; 2008 Jan; 28(1):122-33. PubMed ID: 18164221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualizing Endogenous Effector T Cell Egress from the Lymph Nodes.
    Menon M; Benechet AP; Khanna KM
    Methods Mol Biol; 2017; 1591():59-71. PubMed ID: 28349475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halted Lymphocyte Egress via Efferent Lymph Contributes to Lymph Node Hypertrophy During Hypercholesterolemia.
    Tay MHD; Lim SYJ; Leong YFI; Thiam CH; Tan KW; Torta FT; Narayanaswamy P; Wenk M; Angeli V
    Front Immunol; 2019; 10():575. PubMed ID: 30972070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCG Skin Infection Triggers IL-1R-MyD88-Dependent Migration of EpCAMlow CD11bhigh Skin Dendritic cells to Draining Lymph Node During CD4+ T-Cell Priming.
    Bollampalli VP; Harumi Yamashiro L; Feng X; Bierschenk D; Gao Y; Blom H; Henriques-Normark B; Nylén S; Rothfuchs AG
    PLoS Pathog; 2015 Oct; 11(10):e1005206. PubMed ID: 26440518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential activation of CD8+ T cells in the draining lymph nodes in response to pulmonary virus infection.
    Yoon H; Legge KL; Sung SS; Braciale TJ
    J Immunol; 2007 Jul; 179(1):391-9. PubMed ID: 17579060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic cells enhance sphingosine-1-phosphate receptor 1 dependent macrophage migration.
    Weichand B; Weis N; Weigert A; Grossmann N; Levkau B; Brüne B
    Eur J Immunol; 2013 Dec; 43(12):3306-13. PubMed ID: 23934754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics.
    Ledgerwood LG; Lal G; Zhang N; Garin A; Esses SJ; Ginhoux F; Merad M; Peche H; Lira SA; Ding Y; Yang Y; He X; Schuchman EH; Allende ML; Ochando JC; Bromberg JS
    Nat Immunol; 2008 Jan; 9(1):42-53. PubMed ID: 18037890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine 1-phosphate receptors regulate chemokine-driven transendothelial migration of lymph node but not splenic T cells.
    Yopp AC; Ochando JC; Mao M; Ledgerwood L; Ding Y; Bromberg JS
    J Immunol; 2005 Sep; 175(5):2913-24. PubMed ID: 16116177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17-Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions.
    Maeda Y; Seki N; Kataoka H; Takemoto K; Utsumi H; Fukunari A; Sugahara K; Chiba K
    J Immunol; 2015 Aug; 195(4):1408-16. PubMed ID: 26170380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.
    Coles RM; Mueller SN; Heath WR; Carbone FR; Brooks AG
    J Immunol; 2002 Jan; 168(2):834-8. PubMed ID: 11777979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8 T Cells Enter the Splenic T Cell Zones Independently of CCR7, but the Subsequent Expansion and Trafficking Patterns of Effector T Cells after Infection Are Dysregulated in the Absence of CCR7 Migratory Cues.
    Sharma N; Benechet AP; Lefrançois L; Khanna KM
    J Immunol; 2015 Dec; 195(11):5227-36. PubMed ID: 26500349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine-1-phosphate receptor 2 restrains egress of γδ T cells from the skin.
    Laidlaw BJ; Gray EE; Zhang Y; Ramírez-Valle F; Cyster JG
    J Exp Med; 2019 Jul; 216(7):1487-1496. PubMed ID: 31160320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRTAM confers late-stage activation of CD8+ T cells to regulate retention within lymph node.
    Takeuchi A; Itoh Y; Takumi A; Ishihara C; Arase N; Yokosuka T; Koseki H; Yamasaki S; Takai Y; Miyoshi J; Ogasawara K; Saito T
    J Immunol; 2009 Oct; 183(7):4220-8. PubMed ID: 19752223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.